Back
Marks & Spencer Group PLC Vs. Corcept Therapeutics Industry Stock Comparison
Buy
57
MAKSY
Marks & Spencer Group PLC
Last Price:
10.02
Seasonality Move:
6.5%
Buy
74
CORT
Corcept Therapeutics
Last Price:
40.92
Seasonality Move:
-0.77%
Buy
57
Marks & Spencer Group PLC (MAKSY)
is a Buy
Is Marks & Spencer Group PLC a Buy, Sell or Hold?
- The current Marks & Spencer Group PLC [MAKSY] share price is $10.02. The Score for MAKSY is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- MAKSY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $40.92. The Score for CORT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MAKSY Stock Price Chart
What is Marks & Spencer Group PLC's stock price today?
-
The Marks & Spencer Group PLC share price today is $10.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MAKSY is experiencing slight selling pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $40.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
MAKSY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 81.55 | Buy |
Chaikin Money Flow: | -6080 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.57 - 9.53) | Buy |
Bollinger Bands (100): | (7.14 - 8.8) | Buy |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.55 | Buy |
Relative Strength Index (14 RSI): | 72.34 | Buy |
Chaikin Money Flow: | -986948 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.51 - 37.97) | Buy |
Bollinger Bands (100): | (28.35 - 36.03) | Buy |
MAKSY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.65 | Buy |
20-day SMA: | 9.2 | Buy |
50-day SMA: | 8.61 | Buy |
200-day SMA: | 7.19 | Buy |
8-day EMA: | 9.69 | Buy |
20-day EMA: | 9.27 | Buy |
50-day EMA: | 8.7 | Buy |
200-day EMA: | 7.35 | Buy |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.22 | Buy |
20-day SMA: | 36.07 | Buy |
50-day SMA: | 35.08 | Buy |
200-day SMA: | 28.51 | Buy |
8-day EMA: | 38.83 | Buy |
20-day EMA: | 36.86 | Buy |
50-day EMA: | 34.93 | Buy |
200-day EMA: | 30.16 | Buy |
Marks & Spencer Group PLC Earnings Growth & MAKSY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
Marks & Spencer Group PLC Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |